Literature DB >> 19628073

Mesenchymal stem cells enhance the viability and proliferation of human fetal intestinal epithelial cells following hypoxic injury via paracrine mechanisms.

Brent R Weil1, Troy A Markel, Jeremy L Herrmann, Aaron M Abarbanell, Daniel R Meldrum.   

Abstract

BACKGROUND: Mesenchymal stem cells (MSCs) may be used to treat injured tissues. The ability of MSCs to treat injured fetal intestinal epithelial cells (FIEs), similar to those in infants with necrotizing enterocolitis, has not been elucidated. We hypothesized that MSCs would enhance FIE viability and proliferation after hypoxic injury via paracrine mechanisms.
METHODS: LLC-PK1 cells (differentiated control [DC]) and human MSCs were exposed to 1 hour of hypoxia. Cells were reoxygenated for 24 hours and cell-free conditioned media were collected. Human FIEs were exposed to 1 hour of hypoxia and plated for experiments. FIEs were reoxygenated in nonconditioned media, DC-conditioned media, or MSC-conditioned media. Supernatants were analyzed for interleukin-6 (IL-6), hepatocyte growth factor (HGF), fibroblast growth factor (FGF), and vascular endothelial growth factor (VEGF) via enzyme-linked immunosorbent assay. Cell viability was assessed by trypan blue exclusion and cell counting. Proliferation was determined via 5-bromo-2'-deoxyuridine (BrdU). Expression of caspases-3 and -8 was determined via Western blot.
RESULTS: FIEs reoxygenated in MSC-conditioned media demonstrated enhanced viability and increased proliferation after hypoxic injury. Enhanced FIE viability and proliferation were associated with increased IL-6, HGF, and VEGF, as well as decreased expression of caspase-3.
CONCLUSION: MSCs may increase the viability and proliferative capacity of FIEs after hypoxic injury via the paracrine release of IL-6, HGF, and VEGF, as well as downregulation of apoptotic signaling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19628073     DOI: 10.1016/j.surg.2009.03.031

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  38 in total

Review 1.  The immunomodulatory properties of mesenchymal stem cells: implications for surgical disease.

Authors:  Brent R Weil; Mariuxi C Manukyan; Jeremy L Herrmann; Aaron M Abarbanell; Jeffrey A Poynter; Yue Wang; Daniel R Meldrum
Journal:  J Surg Res       Date:  2010-08-06       Impact factor: 2.192

2.  Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1.

Authors:  Abolfazl Zarjou; Junghyun Kim; Amie M Traylor; Paul W Sanders; József Balla; Anupam Agarwal; Lisa M Curtis
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-03

Review 3.  Are stem cells a potential therapeutic tool in coeliac disease?

Authors:  Rachele Ciccocioppo; Giuseppina Cristina Cangemi; Emanuela Anna Roselli; Peter Kruzliak
Journal:  Cell Mol Life Sci       Date:  2014-12-16       Impact factor: 9.261

4.  Potential role of stem cells in disease prevention based on a murine model of experimental necrotizing enterocolitis.

Authors:  Courtney Pisano; Gail E Besner
Journal:  J Pediatr Surg       Date:  2018-09-05       Impact factor: 2.545

5.  Heparin-binding epidermal growth factor-like growth factor and mesenchymal stem cells act synergistically to prevent experimental necrotizing enterocolitis.

Authors:  Jixin Yang; Daniel Watkins; Chun-Liang Chen; Bharath Bhushan; Yu Zhou; Gail E Besner
Journal:  J Am Coll Surg       Date:  2012-07-21       Impact factor: 6.113

6.  Bone-marrow mesenchymal stem cells reduce rat intestinal ischemia-reperfusion injury, ZO-1 downregulation and tight junction disruption via a TNF-α-regulated mechanism.

Authors:  Zhong-Yang Shen; Jing Zhang; Hong-Li Song; Wei-Ping Zheng
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

7.  Postinfarct intramyocardial injection of mesenchymal stem cells pretreated with TGF-alpha improves acute myocardial function.

Authors:  Jeremy L Herrmann; Aaron M Abarbanell; Brent R Weil; Yue Wang; Jeffrey A Poynter; Mariuxi C Manukyan; Daniel R Meldrum
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-19       Impact factor: 3.619

Review 8.  Stem cell therapy in necrotizing enterocolitis: Current state and future directions.

Authors:  Natalie A Drucker; Christopher J McCulloh; Bo Li; Agostino Pierro; Gail E Besner; Troy A Markel
Journal:  Semin Pediatr Surg       Date:  2017-11-07       Impact factor: 2.754

9.  Exosomes secreted from bone marrow-derived mesenchymal stem cells protect the intestines from experimental necrotizing enterocolitis.

Authors:  Terrence M Rager; Jacob K Olson; Yu Zhou; Yijie Wang; Gail E Besner
Journal:  J Pediatr Surg       Date:  2016-03-02       Impact factor: 2.545

Review 10.  The role of growth factors in intestinal regeneration and repair in necrotizing enterocolitis.

Authors:  Kathryn J Rowland; Pamela M Choi; Brad W Warner
Journal:  Semin Pediatr Surg       Date:  2013-05       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.